- Home
- WIA vs BWAY Comparison
WIA vs BWAY Comparison
Compare WIA & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- BWAY
- Stock Information
- Founded
- WIA 2003
- BWAY 2003
- Country
- WIA United States
- BWAY Israel
- Employees
- WIA N/A
- BWAY N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- BWAY Medical/Dental Instruments
- Sector
- WIA Finance
- BWAY Health Care
- Exchange
- WIA Nasdaq
- BWAY Nasdaq
- Market Cap
- WIA 186.8M
- BWAY 177.4M
- IPO Year
- WIA N/A
- BWAY 2019
- Fundamental
- Price
- WIA $8.22
- BWAY $10.28
- Analyst Decision
- WIA
- BWAY Strong Buy
- Analyst Count
- WIA 0
- BWAY 3
- Target Price
- WIA N/A
- BWAY $13.17
- AVG Volume (30 Days)
- WIA 39.2K
- BWAY 57.5K
- Earning Date
- WIA 01-01-0001
- BWAY 03-05-2025
- Dividend Yield
- WIA 12.29%
- BWAY N/A
- EPS Growth
- WIA N/A
- BWAY N/A
- EPS
- WIA N/A
- BWAY 0.04
- Revenue
- WIA N/A
- BWAY $38,631,000.00
- Revenue This Year
- WIA N/A
- BWAY $388.82
- Revenue Next Year
- WIA N/A
- BWAY $18.70
- P/E Ratio
- WIA N/A
- BWAY $128.37
- Revenue Growth
- WIA N/A
- BWAY 34.19
- 52 Week Low
- WIA $7.56
- BWAY $4.61
- 52 Week High
- WIA $8.91
- BWAY $11.25
- Technical
- Relative Strength Index (RSI)
- WIA 59.46
- BWAY 46.35
- Support Level
- WIA $8.09
- BWAY $10.24
- Resistance Level
- WIA $8.21
- BWAY $10.89
- Average True Range (ATR)
- WIA 0.09
- BWAY 0.47
- MACD
- WIA 0.02
- BWAY -0.04
- Stochastic Oscillator
- WIA 73.33
- BWAY 10.34
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.